  Any reliable biomarker has to be specific, generalizable, and reproducible
across individuals and contexts. The exact values of such a biomarker must
represent similar health states in different individuals and at different times
within the same individual to result in the minimum possible false-positive and
false-negative rates. The application of standard cut-off points and risk
scores across populations hinges upon the assumption of such generalizability.
Such generalizability, in turn, hinges upon this condition that the phenomenon
investigated by current statistical methods is ergodic, i.e., its statistical
measures converge over individuals and time within the finite limit of
observations. However, emerging evidence indicates that biological processes
abound with non-ergodicity, threatening this generalizability. Here, we present
a solution for how to make generalizable inferences by deriving ergodic
descriptions of non-ergodic phenomena. For this aim, we proposed capturing the
origin of ergodicity-breaking in many biological processes: cascade dynamics.
To assess our hypotheses, we embraced the challenge of identifying reliable
biomarkers for heart disease and stroke, which, despite being the leading cause
of death worldwide and decades of research, lacks reliable biomarkers and risk
stratification tools. We showed that raw R-R interval data and its common
descriptors based on mean and variance are non-ergodic and non-specific. On the
other hand, the cascade-dynamical descriptors, the Hurst exponent encoding
linear temporal correlations, and multifractal nonlinearity encoding nonlinear
interactions across scales described the non-ergodic heart rate variability
ergodically and were specific. This study inaugurates applying the critical
concept of ergodicity in discovering and applying digital biomarkers of health
and disease.
